RCKT stock results show that Rocket Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. More
Articles
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Misses Revenue for Q1 2024
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024
RANI stock results show that Rani Therapeutics Hldgs beat analyst estimates for earnings per share the first quarter of 2024. More
PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q1 2024
PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
ORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024
ORIC stock results show that ORIC Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. More
BWMN Stock Earnings: Bowman Consulting Group Beats EPS, Misses Revenue for Q1 2024
BWMN stock results show that Bowman Consulting Group beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
ADEA Stock Earnings: Adeia Beats EPS, Beats Revenue for Q1 2024
ADEA stock results show that Adeia beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
